UNSPSC 51181932: Lutropin alfa

Lutropin alfa is a recombinant human luteinizing hormone for the treatment of infertility in women with hypothalamic or pituitary insufficiency (hypogonadotropic hypogonadism) and profound LH deficiency.

UNSPSC 51181932 Lutropin alfa, a Commodity code, has minimal recent activity in the state and local procurement environment. The source contains no solicitations actually seeking this pharmaceutical product — a recombinant gonadotropin hormone used in fertility treatment. Instead, recent records tagged under or near this code include administrative notices (Williamson County's office relocation), vendor networking events, and procurement surveys unrelated to lutropin alfa or specialty pharmaceuticals. Of the state and local opportunities posted January through July 2026, none represent active demand for this specific product.

The code's minimal market visibility reflects the nature of specialty pharmaceutical procurement at the state and local level. Most lutropin alfa distribution channels operate through state Medicaid programs, health plans, and specialty pharmacy networks rather than through competitive bidding notices. Without recent RFPs, RFQs, ITBs, or IFBs naming lutropin alfa or equivalent gonadotropin products, no geographic concentration, issuing-body pattern, or representative solicitation can be identified. A broader search across state pharmaceutical schedules, Medicaid managed care procurement, and specialty pharmacy cooperative purchasing vehicles would be necessary to locate actual procurement activity in this commodity.